Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

CPC-111 moves toward pivotal trials for bypass surgery

July 10, 1997

Yamanouchi, Ferring collaborate on endothelin antagonists

July 10, 1997

New lactam compounds for sepsis and RA

July 10, 1997

Low-dose combination of ramipril and felodipine evaluated in SHR

July 9, 1997

Fixed-dose losartan/hydrochlorothiazide combination now available in U.K.

July 8, 1997

Potent, selective and orally active ETA antagonist from Zeneca

July 8, 1997

Agent for restenosis in preclinical development at CV Therapeutics

July 7, 1997

New cardiovascular agent in development at CV Therapeutics

July 7, 1997

New agents for tachycardia from CV Therapeutics

July 7, 1997

RPR licenses Dilacor XR to Watson

July 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...